MEDICINE & HEALTHThe Novavax vaccine works like other COVID-19 vaccines by teaching the immune system to make antibodies to the coronavirus spike protein.
Pfizer CEO Albert Bourla said that a booster shot of the COVID-19 vaccine is likely needed within 12 months to get fully vaccinated. He added that annual revaccination might be needed, like flu shots.
The FDA and CDC recently called for a pause in the use of the Jonson & Johnson COVID19 vaccine after receiving reports of 6 cases of a rare and severe type of blood clotting.
While existing intramuscular vaccines offer effective systemic immunity against COVID-19, mucosal immunity through intranasal vaccines is needed to fully block transmission and prevent the spread of new variants.
Pfizer has asked the FDA for an amendment to its emergency use authorization for its COVID-19 vaccine to expand its use in individuals aged 12 to 15 in the United States.
Experts say one COVID-19 side effect known as 'Moderna arm' or 'COVID arm,' a delayed-onset rash appearing at the injection area up to one week or so after a shot is given, is harmless.
Striking images recently revealed how the AstraZeneca COVID-19 vaccine is forcing an injected person's own cells to make copies of the real COVID-19 spike, a glycoprotein sticking out from its surface.
Experts say that it is vital to complete the two-dose vaccine shot to be completely protected. If a COVID-19 vaccine requires two doses, experts say, no major change should take place after getting the first shot.
The US Centers for Disease Control and Protection updated its guidance, easing travel restrictions for fully vaccinated people due to the FDA-approved vaccines' high efficacy rate.
Pfizer announced that the Pfizer-BioNTech COVID-19 vaccine showed a 100-percent efficacy and is well-tolerated in younger people whose ages range between 12 and 15 years.
The Pfizer-BioNTech COVID-19 vaccine just got the EU regulator's approval to be stored at a new higher temperature. This is part of their initiative to help in the rapid rollout of vaccines.
Large clinical trial results have revealed that the AstraZeneca COVID-19 vaccine is well-tolerated and it shields from symptomatic COVID-19 injection, including severe disease or hospital confinement.
Oravax, a pharmaceutical company, is developing an oral COVID-19 vaccine that would be easier to store, ship, and administer as compared to commonly used intravenous vaccines.
Experts say that a vaccine that could prevent hospitalization, reduce mortality, and halt the spread of asymptomatic infections holds the key to finally halting and containing COVID-19.
A preprint study confirms the first confirmed case of a baby born with COVID-19 antibodies after the mother gets vaccinated when she was 36 weeks pregnant.